can you breastfeed while taking glp 1 Is Semaglutide Safe Breastfeeding? I Actually Lost Weight While

Description

However, Zepbound is an active ingredient, and Tirzepatide is potentially even more effective

U.S.: The Food and Drug Administration (FDA) is the primary regulatory body, ensuring the safety and efficacy of incretin mimetics like Exenatide, Liraglutide, Dulaglutide, and Semaglutide

Your prescriber monitors your response just as they would with any GLP-1 therapy, adjusting treatment based on your results

Here is how GLP-1 options compare, according to clinical trials: Daily oral semaglutide (Wegovy): Average weight loss of 13.6 percent of body weight after about 15 months of treatment, compared with 2.2 percent in a placebo group Average weight loss of 11.2 percent of body weight after 72 weeks of treatment, compared with 2.1 percent in the placebo group